POS1384-HPR THE FUTURE OF PATIENT EDUCATION: DESIGN FOR A WEB PLATFORM FOR EDUCATION IN RHEUMATOID ARTHRITIS
Authors: G. S. Rodríguez-Vargas, F. Rodriguez, N. Pinto-Florez, L. Realpe, A. Rojas-Villarraga, P. Santos-Moreno
Journal: Annals of the Rheumatic Diseases (2023)

<h3>Background</h3> In 2018, a multi-component educational program called UniversitAR was launched. This program was aimed at patients diagnosed with Rheumatoid Arthritis. In the process of training the patients, topics such as clinimetry, comprehensive treatment of the disease, healthy lifestyles, and the enhancement of personal and interaction skills were included. After 3 years of implementation of this program, the certification of 91 expert patients in rheumatoid arthritis was achieved. However, there is a major challenge for health education to have a greater reach for the entire population. <h3>Objectives</h3> The objective of this study is to design a digital education platform, with reach for patients in any country in Latin America and the Caribbean and with a thematic content that is effective for the care of their disease and the improvement of their quality of life. <h3>Methods</h3> A review and digital adaptation of the 3 educational levels of UniversitAR was made. It was considered feasible to maintain the 3 levels of education to respect the criteria of social inclusion, which is a fundamental principle of the multicomponent educational program (Level 1: Basic Knowledge of the Disease Program, Level 2: Patient Empowerment Program for Effective Self-Management of the Disease and Level 3: Expert Patient Program). Contents were updated, the total training time was reduced and evaluation and measurement criteria were added for each educational level. A total of 104 educational sessions were reviewed, as well as the measurements included in the training process in aspects such as: the level of disease activity, autonomy and independence, quality of life and satisfaction with the educational program. <h3>Results</h3> The multicomponent educational program was reconstructed, reducing the educational program from 104 to 84 educational sessions and minimizing the academic intervention times in each session. The total estimated training time for the patient went from 22 months to be carried out in a period between 8 months and 1 year, considering that it will be the patient who will decide the number of sessions they want to see per day. In December 2022, an event for patients with Rheumatoid Arthritis was held and a demo of the platform was presented. The official launch of this digital educational program will be in the third quarter of 2023 and the training of 600 patients is expected this year. <h3>Conclusion</h3> The creation of alternatives that facilitate the education of patients, such as digital platforms, are very important strategies that allow reaching the population, since this breaks down access barriers such as: the geographical location of the patient with respect to their place of training, mobility limitations and out-of-pocket expenses incurred to attend your training sessions. <h3>REFERENCES:</h3> NIL. <h3>Acknowledgements:</h3> NIL. <h3>Disclosure of Interests</h3> Gabriel-Santiago Rodríguez-Vargas: None declared, Fernando Rodriguez: None declared, NORALMA PINTO-FLOREZ: None declared, Liliana Realpe: None declared, Adriana Rojas-Villarraga: None declared, Pedro Santos-Moreno Speakers bureau: Abbvie, Abbott, Biopas-UCB, Bristol, Janssen, Pfizer, Roche, Sanofi, Grant/research support from: Abbvie, Abbott, Biopas-UCB, Bristol, Janssen, Pfizer, Roche, Sanofi.